Peter Park




Peter S. Park is the Director of Business Operations for the Technology Ventures Office of Cedars-Sinai Medical Center, where he manages Cedars-Sinai’s equity portfolio and provides operational oversight and support of key strategic institutional initiatives, including the Cedars-Sinai Biomanufacturing Center (CBC). At the CBC, Mr. Park oversees all aspects of operational readiness of the cGMP biomanufacturing facility, as well as strategic planning, business development and revenue enhancement of both the cGMP and iPSC Core business operations. Prior to joining Cedars-Sinai, Mr. Park was Vice President of Corporate Development & Strategic Alliances for the U.S. operations of CHA Group, an international biotechnology and healthcare company. Before transitioning into a full-time business role, he served in various in-house legal positions, ranging from general counsel of a venture-backed technology startup company to principal deal counsel for the corporate headquarters of Samsung Electronics Co., Ltd. and Samsung Bioepis. Mr. Park also worked as an attorney in the business and technology departments of the law firms of Morgan, Lewis & Bockius and Brobeck, Phleger & Harrison, where he specialized in venture capital, mergers and acquisitions and public offerings. Mr. Park holds a Bachelor of Arts degree in Spanish and a Bachelor of Science degree in molecular and cellular biology from the University of Arizona and earned his law degree from the Santa Clara University School of Law. He is a member of the State Bar of California and is a registered patent attorney with the U.S. Patent and Trademark Office.